SCHEMBL15917691

SCHEMBL15917691

O=S(=O)(NC1CCNCC1)c1ccccc1Br

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.74
HTR1A P08908 2/20 0.52
HTR7 P34969 2/20 0.52
CCR8 P51685 1/20 0.49
WNT3 P56703 1/20 0.49
SFRP1 Q8N474 1/20 0.49
ALDH1A1 P00352 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
BRD4 O60885 2/20 0.43
BRD2 P25440 2/20 0.43
BRD3 Q15059 2/20 0.43
ALOX5AP P20292 1/20 0.43
FEN1 P39748 1/20 0.43
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA4 P22748 1/20 0.42
CA6 P23280 1/20 0.42
HTT P42858 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15915474 0.91 MAPT (0.66) MAPTHTR1AHTR7CCR8WNT3
SCHEMBL15915476 0.91 MAPT (0.66) MAPTHTR1AHTR7CCR8WNT3
SCHEMBL15915182 0.89 MAPT (0.87) MAPTHTR1AHTR7ALDH1A1L3MBTL1
SCHEMBL15915230 0.85 MAPT (1.00) MAPTHTR1AHTR7ALDH1A1L3MBTL1
SCHEMBL15916526 0.84 MAPT (0.97) MAPTHTR1AHTR7ALDH1A1L3MBTL1
SCHEMBL15915579 0.81 MAPT (0.74) MAPTHTR1AHTR7ALDH1A1L3MBTL1
SCHEMBL15916455 0.81 MAPT (0.74) MAPTHTR1AHTR7ALDH1A1L3MBTL1
SCHEMBL15915581 0.81 MAPT (0.74) MAPTHTR1AHTR7ALDH1A1L3MBTL1
SCHEMBL4623414 0.81 BRD4 (0.55) MAPTCCR8WNT3SFRP1ALDH1A1
SCHEMBL15916457 0.81 MAPT (0.74) MAPTHTR1AHTR7ALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3495359-A1 FLAP MODULATORS Janssen Pharmaceutica NV (BE) 2019-06-12 EP disclosed
EP-3070085-B1 FLAP MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2019-01-09 EP disclosed
EP-2951170-B1 FLAP MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2018-10-24 EP disclosed
US-9884878-B2 FLAP modulators JANSSEN PHARMACEUTICA NV (BE) 2018-02-06 US disclosed
US-9745328-B2 Flap modulators JANSSEN PHARMACEUTICA NV (BE) 2017-08-29 US disclosed
EP-3070085-A1 FLAP MODULATORS Janssen Pharmaceutica N.V. (BE) 2016-09-21 EP disclosed
US-20150376212-A1 FLAP MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2015-12-31 US disclosed
US-20150259357-A1 FLAP MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2015-09-17 US disclosed
US-9079866-B2 Flap modulators JANSSEN PHARMACEUTICA NV (BE) 2015-07-14 US disclosed
US-20140221311-A1 FLAP MODULATORS JANSSEN PHARMACEUTICA NV (US) 2014-08-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150376212-A1 FLAP MODULATORS FEN1, PGF, TBXA2R MAPT 4864/4885HTR1A 667/4885HTR7 3481/4885
US-20150259357-A1 FLAP MODULATORS PGF, FEN1, TBXA2R MAPT 4867/4885HTR1A 1244/4885HTR7 3440/4885
US-20140221311-A1 FLAP MODULATORS PGF, FEN1, TBXA2R MAPT 4867/4885HTR1A 1244/4885HTR7 3440/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.